Lori J. Sokoll

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• A Biomarker Panel for the Detection of Pancreatic Cancer

  Cancers · 2026-04-28

• Combining Serum Prostate Health Index With Urinary PCA3 and TMPRSS2:ERG RNA Testing Improves Detection of Clinically Significant Prostate Cancer

  JU Open Plus · 2026-02-01 · 3 citations

• Supplementary Data 2 from Diagnostic Performance of a Tumor Marker Gene Test to Personalize Serum CA19–9 Reference Ranges

  2025-11-25

• Supplementary Data Tables S1-S5 from Diagnostic Performance of a Tumor Marker Gene Test to Personalize Serum CA19–9 Reference Ranges

  2025-11-25

• Supplementary Data 1 from Diagnostic Performance of a Tumor Marker Gene Test to Personalize Serum CA19–9 Reference Ranges

  2025-11-25

• Supplementary Table S5 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial

  2025-11-25

• Supplementary Figure S3 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial

  2025-11-25

• Supplementary Table S3 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial

  2025-11-25

• Supplementary Table S4 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial

  2025-11-25

• Supplementary Table S2 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial

  2025-11-25

• Supplementary Figure S4 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial

  2025-11-25

• Supplementary Table S1 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial

  2025-11-25

• Supplementary Figure S2 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial

  2025-11-25

• Supplementary Table S6 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial

  2025-11-25

• Abstract 4345537: Development and Validation of a Simplified Martin/Hopkins Low-Density Lipoprotein Cholesterol Equation Using Machine Learning

  Circulation · 2025-11-03

• Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer

  Cell · 2025-11-01 · 33 citations

• Aldosterone Levels Post-IV Saline Suppression Using Commercial Reference Laboratory Liquid Chromatography-Tandem Mass Spectrometry Assay

  AACE Endocrinology and Diabetes · 2025-09-04

• Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial.

  UNC Libraries · 2025-01-23

• Data from Early Detection of Ovarian Cancer Using Cell-Free DNA Fragmentomes and Protein BiomarkersPreprint

  2025-01-13

• Supplementary Figures from Early Detection of Ovarian Cancer Using Cell-Free DNA Fragmentomes and Protein BiomarkersPreprint

  2025-01-13 · 1 citations